0001209191-23-047913.txt : 20230901 0001209191-23-047913.hdr.sgml : 20230901 20230901082011 ACCESSION NUMBER: 0001209191-23-047913 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230831 FILED AS OF DATE: 20230901 DATE AS OF CHANGE: 20230901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Su Zhen CENTRAL INDEX KEY: 0001991642 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 231230690 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SUITE 210 CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc. CENTRAL INDEX KEY: 0001503802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263931704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-658-0600 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-31 0 0001503802 Karyopharm Therapeutics Inc. KPTI 0001991642 Su Zhen C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE NEWTON MA 02459 1 0 0 0 0 Nonstatutory Stock Option (right to buy) 1.28 2023-08-31 4 A 0 68000 0.00 A 2033-08-30 Common Stock 68000 68000 D This option was granted on August 31, 2023. The shares underlying the option vest as to one-third (1/3) of the shares on August 31, 2024 and as to the remaining two-thirds (2/3) of the shares in 24 equal monthly installments thereafter. /s/Nancy Smith as Attorney-in-Fact for Zhen Su 2023-09-01